Our sustainability goals and targets

As a global biopharma leader, we want to play our full part in protecting and restoring the planet’s health, in order to protect and improve people’s health. Improving the environmental sustainability of our business makes us more resilient, so we can deliver the products that patients rely on.
Scientific evidence is increasingly demonstrating how climate change and nature loss are impacting the world and human health. For example, human health is under threat from air pollution, diseases that pass from animals to humans and threats to water security. Climate and nature changes are testing the resiliency of healthcare systems.
As a global biopharma leader, addressing our environmental impact is fundamental to our purpose. That’s why we have set ambitious climate and nature targets.
Net zero impact on climate
Our climate action targetsTo deliver our goal to have a net zero impact on climate, we have set the following long-term targets:
- 80% absolute reduction in greenhouse gas emissions1 from a 2020 baseline, across all scopes2 and investment in nature-based solutions for the remaining 20% of our footprint by 2030
- 100% imported renewable electricity by 2025 and 100% renewable electricity (imported and generated) by 2030 (Scope 2)
- Net zero greenhouse gas emissions across our full value chain by 2045: 90% absolute reduction in emissions from a 2020 baseline, across all scopes and all residual emissions neutralised.
The Science Based Target initiative (SBTi) has approved GSK’s net zero target for 2045 in line with their Corporate Net-Zero Standard, the world’s only framework for corporate net-zero target setting in line with climate science.
1 Previously stated as net zero by 2030
2 This is a new longer-term target, aligned to the SBTi Net-Zero Standard definition of net zero
Contributing to nature positive world
Our nature action targetsFreshwater
- Achieve good water stewardship at 100% of our sites by 2025
- Achieve zero impact active API levels1 for all sites and key suppliers by 2030
- Be water neutral in our own operations and at key suppliers in water-stressed regions by 2030*
Land
- Positive impact on biodiversity at all GSK owned sites by 2030
- 100% of key naturally-derived materials sustainably sourced and deforestation free by 20302*
Oceans
- 100% of marine-derived materials to be sustainably sourced by 2030
Atmosphere
- 80% reduction in carbon emissions across our full value chain by 2030*
- 100% renewable electricity by 2025 (Scope 2)*
- Net zero carbon emissions across our full value chain by 2045*
Waste and materials
- Zero operational waste3 by 20304 *
- 10% waste reduction from supply chain by 2030
- 25% environmental impact reduction for our products and packaging by 2030
1 Below the predicted no-effect level, as defined by the AMR Alliance and API Wastewater discharge limits
2 Definition clarified in 2024 to reflect priority materials
3 Including a 20% reduction in routine hazardous and non-hazardous waste
4 Target updated in 2024 to remove specific reference to the elimination of operational single-use plastics. This work has been integrated into the overall operational waste target.)
* Linked with the remuneration of our senior leaders
Reporting
We report progress against these underlying targets and goals on an annual basis, disclosed as part of our Annual Report and Responsible Business reporting

Find out about our sustainability focus areas
What sustainability means for GSK
Delivering our sustainability targets is not just important for planetary and human health. It’s important for us as a business in terms of supporting growth, mitigating risk and getting ahead of legislation.
As countries around the world commit to low carbon healthcare systems, we are seeing increasing demand from customers, healthcare practitioners and patients for sustainable products. We understand this is an issue that many of our people are passionate about.
We are GSK
Meet some of the remarkable GSK people working to have a positive impact for patients and the planet.

Engage with Claire Lund
To keep up-to-date with our latest sustainability news, follow our Global Vice President - Sustainability, Claire Lund, on LinkedIn.
More on our sustainability commitments
- GSK Sustainable Sourcing Standards (PDF - 879.7KB)
- Understanding Impact And Dependencies On Nature (PDF - 4.8MB)
- GSK Sustainability And Global Health Update At COP27 (PDF - 100.6KB)
- Sharing our journey to net zero and nature positive for a healthier future (PDF - 924.3KB)
- GSK Position On Environmental Sustainability (PDF - 467.1KB)
- GSK Environmental Action Report 2022 (PDF - 1.8MB)